Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SOLARA | NSE
33.55
7.88%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
01/04/2026
459.10
440.00
466.00
440.00
Solara Active Pharma Sciences Limited manufactures produces processes formulates sells imports exports merchandises distributes trades in and deals in active pharmaceutical ingredients (API) in India. The company offers APIs for anesthetics anthelmintic anti-arrhythmic agent anti-asthmatic anti-hypertensive anti-inflammatory anti-Parkinson anti-viral antibiotic anticoagulant anticonvulsant antidepressant antiemetic antiepileptic antifungal antigout agent antihistamine antihyperlipoproteinemic antimalarial antimycotic antineoplastic detoxifying agent antiprotozoal agent antipsoriatic antipsychotic antitubercular antitussive antiulcerative anxiolytic bile acid analogue calcimimetic agent cardiovascular agent central nervous system agent chronic alcoholism chronic kidney disease dopamine receptor antagonist folate analog hyperkalaemia immunosuppressant lipid regulating agent loop diuretic muscarinic agonist neuromuscular OAB treatment phenylalanine reducer recovery of stroke tardive dyskinesia treatment of glaucoma and hyperphosphatemia tropical anti-infective and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs including contract development and manufacturing analytical services impurity synthesis and regulatory support. In addition the company exports its products. It operates in the Asia Pacific Europe North America South America and internationally. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai India.
View LessHigh Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
62.0%1 month
44.2%3 months
40.4%6 months
39.5%-
-
4.04
1.08
0.43
-21.14
3.52
-
-716.75M
19.89B
213.48M
-
4.64
98.40
3.20
-46.49
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
46.50
Range1M
57.00
Range3M
166.05
Rel. volume
0.96
Price X volume
41.46M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Unichem Laboratories Limited | UNICHEMLAB | Drug Manufacturers-Specialty & Generic | 298.2 | 21.07B | 1.62% | n/a | 10.48% |
| Morepen Laboratories Limited | MOREPENLAB | Drug Manufacturers-Specialty & Generic | 37.2 | 20.55B | 10.45% | 37.53 | 3.42% |
| Panacea Biotec Limited | PANACEABIO | Biotechnology | 325.3 | 20.30B | 9.88% | n/a | 2.49% |
| Hikal Limited | HIKAL | Drug Manufacturers-Specialty & Generic | 159.96 | 19.72B | 8.76% | 69.03 | 68.84% |
| Alembic Limited | ALEMBICLTD | Drug Manufacturers-Specialty & Generic | 76.49 | 19.71B | 7.88% | 12.29 | 0.42% |
| Indoco Remedies Limited | INDOCO | Drug Manufacturers-Specialty & Generic | 187.08 | 17.24B | 14.07% | 42.22 | 60.54% |
| Windlas Biotech Limited | WINDLAS | Drug Manufacturers-Specialty & Generic | 767.65 | 16.10B | 4.19% | 35.85 | 0.81% |
| Amrutanjan Health Care Limited | AMRUTANJAN | Drug Manufacturers-Specialty & Generic | 499.5 | 14.45B | 1.19% | 52.36 | 0.60% |
| Lincoln Pharmaceuticals Ltd | LINCOLN | Drug Manufacturers-Specialty & Generic | 594.85 | 11.91B | 5.29% | 13.55 | 0.18% |
| Hester Biosciences Limited | HESTERBIO | Drug Manufacturers-Specialty & Generic | 1365.6 | 11.62B | 8.46% | 104.15 | 83.75% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 101.34 | 14.93B | 12.25% | 28.83 | 43.67% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 231.11 | 13.55B | 4.36% | 30.54 | 80.30% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 189.42 | 6.76B | 0.17% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 151.06 | 4.88B | 9.69% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 57.49 | 1.59B | 4.99% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 83.8 | 1.22B | 13.34% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 65.89 | 734.59M | 4.50% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 22.89 | 397.37M | 3.95% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 6.92 | 151.62M | 14.38% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -21.14 | 24.85 | Cheaper |
| Ent. to Revenue | 3.52 | 11.40 | Cheaper |
| PE Ratio | - | 51.36 | - |
| Price to Book | 4.04 | 6.83 | Cheaper |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 40.40 | 42.17 | Par |
| Debt to Equity | 1.08 | 0.35 | Expensive |
| Debt to Assets | 0.43 | 0.17 | Expensive |
| Market Cap | 19.89B | 290.82B | Emerging |